Fintech CEO Questions UK's Private Share Trading Scheme
Tim Levene, CEO of Augmentum Fintech, voices significant concerns over the UK's proposed private share trading scheme, highlighting liquidity and valuation challenges for investors.
Category : Search result: pharmaceutical shares
Cash ISA limit cut to £12,000 from 2027
Chancellor Rachel Reeves reduces the cash ISA allowance to boost investment. Discover why tax-free savings remain vital and how to navigate the new rules before the 2027 deadline.
UK-US Pharma Deal: NHS to Pay 25% More for New Drugs
A new UK-US deal doubling spending on US medicines raises NHS funding fears. Experts warn of a 'problematic precedent' that could impact Australia and global healthcare systems.
UK-US agree zero tariff deal on pharmaceuticals
The UK has secured a major three-year deal for zero US import tariffs on pharmaceuticals, safeguarding £5bn in annual exports and boosting life sciences investment. Read the full analysis.
UK-US zero-tariff pharma deal, NHS drug price rise
The UK and US have agreed a landmark deal maintaining zero tariffs on pharmaceuticals, while the NHS commits to a 25% net price increase for new medicines. Explore the details and implications.
US and UK agree zero-tariffs on pharmaceuticals
The US has agreed to spare the UK from threatened trade tariffs on pharmaceutical products, ensuring access to latest medical breakthroughs. Read the full details.
FDA Implements Stricter Vaccine Approval Protocols
US regulator FDA announces major overhaul of vaccine approval process following COVID-19 review. New protocols aim to strengthen public trust in immunisation programmes.
UK Budget 2025: Online Gambling Tax Doubles to 40%
Chancellor Rachel Reeves announces near-doubling of remote gaming duty to 40%, raising £1.1bn by 2030. Discover how this impacts gambling shares and government funding.
Bank shares surge after escaping Budget tax raid
Lloyds and NatWest shares jumped as Chancellor Rachel Reeves spared banks from a tax hike in the Autumn Budget. Discover the market reaction and industry relief.
Stamp Duty Holiday Aims to Boost London IPOs
The UK government introduces a stamp duty suspension on company shares to attract more IPOs to London, countering competition from New York and European markets.
Molten Ventures Eyes Further Revolut Share Sales
Major shareholder Molten Ventures plans further Revolut stake sales despite $75bn valuation surge after Nvidia investment. Discover the portfolio strategy behind the move.
Bank shares volatile amid Treasury Budget leaks
UK bank stocks experience dramatic swings as Treasury's conflicting Budget leaks create market uncertainty. Lloyds and Barclays see-saw while tax hike rumours persist. Analysis inside.
UK Bank Shares Jump on Budget Tax Reprieve Hopes
NatWest, Lloyds and Barclays stocks rise as investors anticipate Rachel Reeves will spare lenders from further levy in this week's budget. Discover the market reaction.
Novo Nordisk shares slide after Ozempic pill fails
Novo Nordisk shares slumped over 10% after its Ozempic pill failed to slow Alzheimer's progression in major trials. Read the latest on the pharmaceutical giant's market struggles.
Julius Baer shares plunge 12% amid investor scepticism
Julius Baer shares plummet 12% as investors question CEO's transformation strategy. Can the Swiss bank regain market confidence? Analysis inside.
Babcock Shares Wobble on Mixed Investor Sentiment
Defence giant Babcock reports robust H1 results with profit up 19%, but its share price fluctuates as investors debate future prospects. Discover the full analysis here.
Nvidia UK staff get £45m as shares rocket
Nvidia's UK employees gain nearly £45m from a generous share scheme, as the chip giant's profits and global AI dominance surge. Discover the full financial breakdown.
WH Smith CEO quits after damning Deloitte audit
WH Smith CEO Carl Cowling resigns following a critical Deloitte audit revealing major operational flaws. Discover how the stock reacted and what's next for the retailer.
Ocado shares crash 17% after Kroger warehouse closures
Ocado's value drops £350m after US partner Kroger shuts three automated warehouses, described as a 'near knock-out punch' for the UK online grocer.
Global Markets Slide for Fourth Day on Investor Fears
Global markets face a fourth day of losses as tech valuations and US rate cut concerns spook investors. Asia-Pacific stocks hit a one-month low. Read the full analysis.
UK Plans 25% NHS Drug Threshold Rise to End Standoff
UK ministers propose 25% increase in NHS drug cost-effectiveness thresholds to resolve investment row with pharmaceutical giants and boost life sciences sector.
China's Japan travel warning hits tourism shares
Chinese travel advisory for Japan triggers market slump after PM Takaichi's Taiwan remarks. Shiseido shares fall 9% as diplomatic row escalates. Read the full analysis.
Lloyds and Natwest shares fall in budget fears sell-off
Lloyds and Natwest led FTSE 100 falls as UK bank stocks dropped over 2%. Discover the budget fears sparking this sell-off and what analysts say comes next.
Taylor Wimpey shares slump on Budget uncertainty
Taylor Wimpey's shares fell over 3.5% as its CEO blamed challenging market conditions on uncertainty ahead of the UK Budget. Sales and order book values have dropped significantly.
Oxford Instruments shares surge despite profit decline
Oxford Instruments shares jumped nearly 10% as the FTSE 250 firm recovered from early-year disruption. Revenue fell 7.9% to £185.5m, but strong order momentum and semiconductor sales boosted investor confidence.
Investor's £30k ISA success after finfluencer warning
A Cardiff investor reveals how he built a £30,000 portfolio after learning from risky day trading. Discover the dangers of finfluencers and the power of passive investing for long-term growth.
Sainsbury's Share Surge: Investor Frenzy or Sustainable Growth?
Sainsbury's shares rocket as investors bet on takeover bids and strategic shifts, but analysts question whether the momentum can last in Britain's competitive retail landscape.
NHS faces generic-only drug future warns AstraZeneca
The CEO of pharmaceutical giant AstraZeneca warns that UK patients may be limited to generic medicines unless the NHS increases what it pays for innovative new treatments, raising concerns about healthcare quality and medical research funding.
London Tech Stocks Rally After Market Sell-Off
FTSE tech sector bounces back strongly following Tuesday's dramatic sell-off, with major London-listed technology companies leading the charge in Wednesday's trading session.
Novo Nordisk cuts forecasts again as drug demand slows
Danish pharmaceutical giant Novo Nordisk has cut its sales and profit forecasts for the second time in three months, sending shockwaves through the healthcare sector as demand for its blockbuster weight-loss drugs shows signs of slowing.
Page 1 of 2